CALGARY, AB - Nanalysis Scientific Corp. ("Nanalysis"),((NSCI) ((NSCIF) (FRA: 1N1), through its subsidiary RS2D S.A.S. ("RS2D"), is pleased to announce that it has signed multi-million dollar OEM and licensing deal with a European corporation. Rémy Schimpf, Senior VP Sales states "The deal includes an initial payment of roughly $1 million, and a further $2 million in milestone payments over the next [...]

The BD® AbSeq Immune Discovery Panel enables researchers to execute single cell experiments with high efficiency FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of the BD® AbSeq Immune Discovery Panel (IDP), a state-of-the-art, pre-titrated antibody-oligo based discovery tool designed to investigate 30 immune [...]

Acquisition expands Cole-Parmer’s portfolio of life sciences tools and reference standards Chicago, IL and Vernon Hills, IL – GTCR, a leading private equity firm, announced today that its Cole-Parmer (“CP”) portfolio company has acquired ZeptoMetrix Corporation (“ZeptoMetrix”).  ZeptoMetrix is a life sciences developer and manufacturer of quality control standards and verification panels used in molecular [...]

Investors include Baird Capital, Arboretum Ventures and LYZZ Capital; funding will accelerate commercialization of CRISPRclean™ next-generation sequencing technology Life sciences industry veteran Frank Witney joins Jumpcode Board of Directors Jumpcode opens new headquarters in San Diego biotech business hub SAN DIEGO, Calif. – Jumpcode Genomics – a genome technology company focused on improving the understanding of human [...]

Company to Accelerate Mass Manufacturing and Commercialization of Proprietary PCR-Free Multi-Omics Technology Following Year of Rapid Growth Cardea Bio, Inc., a Tech+Bio company integrating molecular biology with semiconductors via Graphene-based biology-gated Transistors, announced today a $6.5M series A extension that brings the A round total above $20M. The new capital infusion is led by the [...]

Transaction Represents Vance Street’s Second Investment out of its Third Fund Vance Street Capital LLC (“Vance Street”), a Los Angeles-based private equity firm, today announced the acquisition of Excel Scientific, Inc. (“Excel”), a leading manufacturer of microplate sealing films and foils used by life science research, university, and testing laboratories as well as biotech companies, [...]

This new research use only kit enables high throughput multiplex detection of SARS-CoV-2 nucleic acid, supports increased sample input and reduces background amplification from possible contaminating genomic DNA. IPSWICH, MA — New England Biolabs® (NEB®) today announced the launch of its Luna® SARS-CoV-2 RT-qPCR Multiplex Assay Kit for real-time detection of SARS-CoV-2 nucleic acid. This research use only (RUO) [...]

Purolite Corporation today announced that it has engaged Evercore Group L.L.C. to assist the Company in growing its Healthcare and Life Sciences Segment. Purolite is exploring strategic acquisitions to accelerate the growth of its business. This announcement follows Purolite’s recent announcement that it is expanding its manufacturing capabilities to address and fulfill the increasing global [...]

Cambridge, United Kingdom: Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announced it has launched a local cloud solution that will enable researchers in China to perform more efficient genomic analysis at scale, helping to improve health outcomes. The announcement follows Congenica’s US$50m Series C [...]

The collaboration will enable direct integration of IDBS digital solutions with the Genedata Biopharma Platform, accelerating the discovery and development of next-generation biotherapeutics Basel, Switzerland & Boston, MA, USA—January 12, 2021—Genedata and IDBS, both leading innovators for biopharma digital transformation, have entered into a strategic partnership to create synergies between their platforms. The combined solution [...]